NEO - NeoGenomics, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
NeoGenomics, Inc.
NeoGenomics Inc operates a network of cancer-related testing laboratories in Ft. Myers and Tampa, Florida, Irvine, California and Nashville, and Tennessee.
IPO Date: December 10, 2012
Sector: Healthcare
Industry: Life Sciences Tools and Services
Market Cap: $2.05B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.37 | 2.54%
Avg Daily Range (30 D): $0.53 | 2.94%
Avg Daily Range (90 D): $0.46 | 3.06%
Institutional Daily Volume
Avg Daily Volume: .77M
Avg Daily Volume (30 D): 1.78M
Avg Daily Volume (90 D): 2.12M
Trade Size
Avg Trade Size (Sh.): 94
Avg Trade Size (Sh.) (30 D): 75
Avg Trade Size (Sh.) (90 D): 84
Institutional Trades
Total Institutional Trades: 4,304
Avg Institutional Trade: $2.25M
Avg Institutional Trade (30 D): $3.51M
Avg Institutional Trade (90 D): $3.15M
Avg Institutional Trade Volume: .13M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $2.89M
Avg Closing Trade (30 D): $6.65M
Avg Closing Trade (90 D): $6.29M
Avg Closing Volume: 171K
 
News
Sep 14, 2026 @ 10:20 AM
Should You Invest in the State Street SPDR S&P Hea...
Source: Zacks.Com
Aug 25, 2026 @ 12:54 PM
State of the Life Sciences Industry to Be Reviewed...
Source: Bcc Research
Jun 25, 2025 @ 6:51 AM
3 Hot Trades for Insiders, But Are They Good Buys ...
Source: Marketbeat.Com
May 6, 2025 @ 4:20 PM
It's Not Too Late to Jump on These Under-the-Radar...
Source: Marketbeat.Com
Apr 8, 2025 @ 8:48 AM
Minimal Residual Disease Testing Market Forecast R...
Source: Researchandmarkets.Com
Financials
  TTM Q1 2026 Q4 2025
Basic EPS
Diluted EPS
Revenue $201.66M $186.67M $190.17M
Gross Profit $91.88M $80.86M $83.34M
Net Income / Loss $2.24M $-17.11M $-9.88M
Operating Income / Loss $-9.77M $-18.24M $-13.41M
Cost of Revenue $109.78M $105.81M $106.83M
Net Cash Flow $-.6M $-13.48M $-4.53M
PE Ratio    
Splits
Apr 16, 2003 1:100
Nov 17, 2000 4:1